Comparable patterns were reported by Xiaohui et al
They have found GLP-1 weight loss injections like Semaglutide, Tirzepatide (Mounjaro, Zepbound), and now Retratutide to be heart protective and safe for long-term use
Semaglutide activates only GLP-1 receptors (not GIP), which produces slightly less dramatic weight loss on average but may come with fewer side effects for certain individuals
Future research is warranted to examine more long-term outcomes of this synergistic therapy at 2, 5, and 10 years to assess the therapeutic efficacy across various populations
Well consider your medical history, lifestyle, and health goals before recommending a medication
Bloated from alcohol Due to it being an inflammatory substance, drinking alcohol may cause swelling in the body